Target Name: LOC105369380
NCBI ID: G105369380
Review Report on LOC105369380 Target / Biomarker Content of Review Report on LOC105369380 Target / Biomarker
LOC105369380
Other Name(s): Uncharacterized LOC105369380, transcript variant X4 | LOC105369380 variant X4

LOC105369380: A Drug Target / Disease Biomarker

LOC105369380 is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the heat shock protein (HSP) family, which are proteins that are expressed in high abundance in response to an increase in the temperature of the cell.

One of the functions of HSPs is to help the cell maintain its stability and prevent excessive heat from damage. HSPs can also play a role in the regulation of cellular processes that are important for the survival and growth of the cell.

LOC105369380 is of particular interest as a potential drug target because it is known to interact with several important cellular processes that are involved in the development and progression of a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the ways that LOC105369380 is involved in these processes is by its role in the regulation of the cytoskeleton. The cytoskeleton is the structure that gives cells their shape and provides support, and it is involved in many important cellular processes, including cell division, migration, and transport of organelles within the cell.

Studies have shown that LOC105369380 plays a role in the regulation of cytoskeletal structure and function. For example, researchers have found that when cells are treated with LOC105369380, the cytoskeleton changes in a way that is associated with the disruption of normal cellular structure and function.

Another way that LOC105369380 is involved in the regulation of cellular processes is by its role in the regulation of the immune system. The immune system is a critical part of the body's defense against infection and disease, and it is involved in the regulation of many important cellular processes, including the development and activation of immune cells, and the regulation of the immune response.

Research has shown that LOC105369380 is involved in the regulation of the immune system by its effects on the cytoskeleton. For example, studies have shown that when cells are treated with LOC105369380, the cytoskeleton changes in a way that is associated with the disruption of normal cellular structure and function, and this disruption can affect the development and activation of immune cells.

In addition to its role in the regulation of the immune system, LOC105369380 is also involved in the regulation of many other cellular processes that are important for the survival and growth of the cell. For example, studies have shown that LOC105369380 plays a role in the regulation of cell division, and that it is involved in the regulation of the production of proteins that are important for cellular processes.

Overall, LOC105369380 is a protein that is involved in a wide range of cellular processes that are important for the survival and growth of the cell. As a potential drug target, LOC105369380 is of particular interest because it is known to interact with several important cellular processes that are involved in the development and progression of a wide range of diseases. Further research is needed to fully understand the role of LOC105369380 in these processes and to develop effective treatments for a variety of diseases.

Protein Name: Uncharacterized LOC105369380, Transcript Variant X4

The "LOC105369380 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105369380 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105369384 | LOC105369388 | LOC105369391 | LOC105369395 | LOC105369401 | LOC105369410 | LOC105369441 | LOC105369455 | LOC105369456 | LOC105369464 | LOC105369501 | LOC105369506 | LOC105369513 | LOC105369530 | LOC105369531 | LOC105369566 | LOC105369568 | LOC105369572 | LOC105369574 | LOC105369603 | LOC105369612 | LOC105369614 | LOC105369617 | LOC105369623 | LOC105369625 | LOC105369628 | LOC105369639 | LOC105369645 | LOC105369655 | LOC105369663 | LOC105369689 | LOC105369698 | LOC105369705 | LOC105369709 | LOC105369710 | LOC105369732 | LOC105369735 | LOC105369736 | LOC105369743 | LOC105369749 | LOC105369750 | LOC105369761 | LOC105369765 | LOC105369772 | LOC105369775 | LOC105369777 | LOC105369780 | LOC105369781 | LOC105369798 | LOC105369806 | LOC105369818 | LOC105369823 | LOC105369830 | LOC105369833 | LOC105369835 | LOC105369838 | LOC105369843 | LOC105369844 | LOC105369850 | LOC105369862 | LOC105369869 | LOC105369879 | LOC105369890 | LOC105369896 | LOC105369923 | LOC105369927 | LOC105369928 | LOC105369944 | LOC105369958 | LOC105369965 | LOC105369976 | LOC105369998 | LOC105370002 | LOC105370003 | LOC105370011 | LOC105370025 | LOC105370027 | LOC105370032 | LOC105370050 | LOC105370073 | LOC105370076 | LOC105370108 | LOC105370109 | LOC105370113 | LOC105370115 | LOC105370127 | LOC105370128 | LOC105370134 | LOC105370135 | LOC105370165 | LOC105370168 | LOC105370174 | LOC105370176 | LOC105370182 | LOC105370204 | LOC105370214 | LOC105370222 | LOC105370243 | LOC105370259 | LOC105370262